Carerx Corporation · TSX:CRRX
Carerx — Investor Presentation (January 2021)
17 slides from Carerx's investor presentation, January 2021
Slide 1: Investor Presentation
Canada’s Largest Seniors Care Pharmacy Provider TSX: CRRX Investor Presentation January 2021
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: Medication supply and management is a critical component of seniors home care
The typical senior Medication supply and in a long-term management is a critical care or retirement component of seniors home care home takes • Optimize medication regimen for best 4 to 12 patient outcomes • Ensure highest levels of safety • Minimize hospital visits • Resident oversight by geriatric
Slide 4: Canada's leading provider of Specialty Pharmacy services to seniors
Large, high-growth seniors market Canada's leading Long-term contracts with high customer retention provider of Specialty Pharmacy High revenue and margin visibility services to seniors Significant scalability in long-term care and operating and retirement leverage homes Multiple organic growth and
Slide 5: Best-in-Class Institutional Pharmacy Capabilities
Best-in-Class Institutional Add an image of a pharmacist at work Pharmacy Capabilities • High-volume solutions for cost-effective supply of chronic medication • Highest level of safety and adherence for individuals with complex medication regimes • Industry-leading team of clinical pharmacists who w
Slide 6: Best-in-Class Medication Management Technology
Best-in-Class Medication Management Technology PACMED® PACVision® Automated strip Automated pouch packaging technology verification technology Digital Pen Nexsys ADC™ Automated dispensing cabinet PharmaPod PharmaConnect Medication incident eMAR Interactive patient portal management system Technology
Slide 7: Our Growing National Footprint
Our Growing Strongest Network in the Sector National Footprint ~50,000 beds serviced >900 seniors homes Geographies: Ontario & Western Canada monthly >1.4 M prescriptions Strong Bed Growth 50,000 18 fulfillment 40,000 centres 30,000 7 20,000 2014 2015 2016 2017 2018 2019 Q3/20
Slide 8: Total beds in Canada
Total beds in Canada Over the next ~15 years, the number of beds is ~425,000 (and growing) forecast to grow 11.8% ~50,000 >2x Comp A 8.2% ~35,000 Comp B 7.8% ~33,000 1,025,000 2.8% Comp C Rest of Market ~12,000 ~295,000 69.4% ~425,000 8 Note: Incumbent bed counts per management estimates; Total mark
Slide 9: Multiple Opportunities for Growth
Multiple Opportunities for Growth Increase beds under contract Well capitalized and positioned to win new large, national and regional contracts Today • Expand with our seniors home customers 2023 Target • Add new seniors homes contracts 50,000 100,000 • Expand into additional provinces Make strateg
Slide 10: Disciplined M&A Strategy
Disciplined M&A Strategy 1 Highly 2 With strong 3 At accretive complementary synergy potential purchase multiples Leverage current Ability to realize Highly accretive market dynamics to substantial synergies acquisitions at make opportunistic through rationalization, discounts to CRRX’s roll-up acqu
Slide 11: Remedy's: A Transformational Acquisition
Remedy’s: A Integration Completed Transformational Ahead of Schedule Acquisition • Consolidation of certain fulfillment • May 2020: Completed acquisition centres primary driver of cost of Remedy’sRx Specialty Pharmacy synergies • Added ~18,500 beds • Reduction to 18 fulfillment centres • Created the
Slide 12: New digital business providing free same-day delivery service
New digital business providing free same-day delivery service • Leverages existing CareRx national platform and technological capabilities • Targets the 6 million Canadian seniors living at-home and other customers • EasyPac™ packaging technology ensures medication adherence • Pharmacist consultatio
Slide 13: Strong Financial Momentum
Strong Financial Momentum Continuing Operations Q3 2020 YTD 2020 Ave. Beds Serviced Revenue Adj. EBITDA Revenue Adj. EBITDA (000s) ($ millions) ($ millions) ($ millions) ($ millions) 45.6 115.8 49.3 8.7 89.1 92.4 31.4 6.9 31.3 27.9 3.8 29.0 2.8 3.1 0.0 Q3 2018 Q3 2019 Q3 2020 Q3 2018 Q3 2019 Q3 2020
Slide 14: Capital Structure
Capital Structure Shares Outstanding (000’s) 2,022 37,871 40,000 11,075 Total Debt 30,000 24,774 (at Sept. 30/20) (millions) 20,000 $4.0 10,000 0 $13.5 Current I/O Convertible Other Total Fully $27.0 Debentures Outstanding Diluted Instruments Fully Diluted Ownership Yorkville 10,011,667 26.4% Vendor
Slide 15: Favourable Near-Term & Long-Term Outlook
Favourable Near-Term & Long-Term Outlook 11.8% Today ~50,000 beds • Q3/20: A new baseline for growth • Remedy’s integration to be completed by year end • Full run-rate synergies to be realized in Q1 • Catalyst transaction for future acquisitions • Aggressively pursue organic growth 88.2% • Significa
Slide 16: Large, high-growth seniors market
1 2 3 Large, high-growth Canada’s largest Leading customer seniors market seniors care value proposition and pharmacy provider national network 4 5 Natural consolidator in Significant operating a highly fragmented leverage market 16 www.carerx.ca
Slide 17: Investor Presentation
TSX: CRRX Investor Presentation January 2021